LineaGen Raises $5.8M For Molecular Diagnostics Firm

Salt Lake City, Utah-based LineaGen said today that it has raised $5.8M in funding from vSpring Capital and Sanderling Biomedical Ventures, along with Mesa Verde Venture Partners. The firm said it is looking to discover and commercialize significant molecular diagnostic innovations. Lineagen said that its initial focus in on diagnostic tools for the advancement of personalized healthcare. More information »